8 reports

In Oct 2008, Japanese brewer Kirin merged its pharmaceutical unit with Kyowa Hakko Kogyo to create Kyowa Hakko Kirin.

  • Filgrastim
  • Pharmaceutical
  • Amgen Inc.
  • Coherus BioSciences, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • ACTIVE COMPANIES: CATEGORY AND PARAMETERS
  • LATE-STAGE MOLECULES (FILED AND PHASE III)

Levolta Pharmaceuticals has identified four compounds that inhibit TNF and are currently being evaluated in pre-clinical studies.

  • Pharmaceutical
  • Therapy
  • Coherus BioSciences, Inc.
  • Mycenax
  • Pfizer Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016
  • Febrile Neutropenia - Products under Development by Companies

NA Intas Pharmaceuticals Ltd.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Coherus BioSciences, Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017 (CONTD..1), H2 2017

The drug was developed by Toko Pharma.

  • Biosimilar
  • Pharmaceutical
  • United States
  • Product Initiative
  • Coherus BioSciences, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

Reddy' s) is a pharmaceutical company.

  • Biosimilar
  • Pharmaceutical
  • United States
  • Product Initiative
  • Coherus BioSciences, Inc.
  • OROX PHARMA ENTERS INTO LICENSING AGREEMENT WITH COHERUS BIOSCIENCES
  • COHERUS BIOSCIENCES INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • Biosimilar
  • Pharmaceutical
  • United States
  • Company
  • Coherus BioSciences, Inc.
  • Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Products under Development by Companies
  • Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Therapeutics under Development by Companies

POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA) - PIPELINE BY MARATHON PHARMACEUTICALS LLC, H## 2016 MARATHON PHARMACEUTICALS LLC MOMENTA PHARMACEUTICALS INC Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural ana

  • Biosimilar
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Coherus BioSciences, Inc.
  • Daiichi Sankyo Company Ltd; Ligand Pharmaceuticals Inc
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017
  • Biosimilar
  • Musculoskeletal Disorder
  • Pharmaceutical
  • United States
  • Coherus BioSciences, Inc.